Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of amlodipine and cephalosporins in the preparation of anti-resistant combination antibiotics

A technology of amlodipine and cephalosporins, which is applied in the field of medical biology and can solve the problems of long development cycle and high cost of research and development of new antibiotics

Active Publication Date: 2020-01-10
易子越
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The treatment of positive drug-resistant bacteria can rely on new β-lactam antibiotics; however, in the short term, drug-resistant bacteria will adapt to new antibiotics again, and the development cost of new antibiotics is high and the development cycle is long

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of amlodipine and cephalosporins in the preparation of anti-resistant combination antibiotics
  • Application of amlodipine and cephalosporins in the preparation of anti-resistant combination antibiotics
  • Application of amlodipine and cephalosporins in the preparation of anti-resistant combination antibiotics

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0092] Experimental Principles and Methods

[0093] 1. Bacterial culture

[0094] 2. Test the inhibition sensitivity of bacteria to different drugs, combinations and concentrations

[0095] 3. Compare the bacterial inhibition sensitivity of various single drugs, and the bacterial inhibition sensitivity of besylate and amlodipine in combination with various corresponding drugs

[0096] 4. Using 96-well bacterial culture plate, absorbance test, (partial) bacterial activity staining

[0097] Experimental Drug Materials

[0098] MRSA

[0099] 1. Drug-resistant S. aureus strains

[0100] The strains are derived from the specimens submitted for clinical examination, and are obtained through bacterial identification and drug sensitivity screening after separation. The detection result of the Mérieux identification instrument VITEK2 is 99%, the biological code: 010402062763231 (the identification result of the instrument is attached).

[0101] 2. Benzenesulfonic acid. Amlodipine...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of medical biology, and particularly relates to application of amlodipine and cephalosporin medicines to preparation of medicine-resistant combined antibiotics. After computational biology indicates that amlodipine has an inhibitory effect on beta-lactam hydrolase, medicine testing is performed by using MRSA and acinetobacter bauamnnii as models, and through combination with cephalosporin antibiotics, a relatively good bacteriostatic effect on the MRSA is achieved; novel application is provided for the amlodipine, and a novel medicinal composition is provided for positive medicine-resistant bacteria; other more effective combinations containing the amlodipine can be further developed; the conventional cephalosporin and amlodipine combinations are mature in technology, few in side effects and low in cost; and the amlodipine and cephalosporin medicines can be applied to preparation of the medicine-resistant combined antibiotics, preparation ofbeta-lactam medicine-resistant bacterium inhibiting combined antibiotics and preparation of medicines for treating respiratory infection, wound infection and infection caused by all positive bacteria.

Description

[0001] a technical field [0002] The invention belongs to the technical field of medicine and biology, and in particular relates to the application of amlodipine and cephalosporins in the preparation of anti-drug-resistant combination antibiotics. [0003] Two background technology [0004] With the abuse of antibiotics, multi-drug resistant bacteria have emerged all over the world, including MRSA and Acinetobacter baumannii. Such bacteria are mostly found in places where antibiotics are abused, such as hospitals. Because multi-drug resistant bacteria are resistant to drugs, the lethal rate is high; on the other hand, bacteria adapt to new antibiotics faster than antibiotics are developed. The treatment of positive drug-resistant bacteria can rely on new β-lactam antibiotics; however, in the short term, drug-resistant bacteria will adapt to new antibiotics again, and the development cost of new antibiotics is high and the development cycle is long. [0005] In addition to ne...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/4422A61K45/06A61K31/546A61P31/04A61P11/00A61P17/02
CPCA61K31/4422A61K31/546A61K45/06A61K2300/00
Inventor 易子越
Owner 易子越
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com